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Dicer is a ribonuclease playing a key role in the biogenesis of microRNAs and small interfering RNAs.
Here we report the identiﬁcation of a novel splice variant of human dicer gene, the ﬁrst one bearing
a modiﬁed coding sequence. It encodes a truncated protein, t-Dicer that lacks the dsRNA-binding
domain and is defective in one of the two RNase III catalytic centers. The splice variant was found
in neuroblastoma cells and in cells induced to neuronal differentiation, whereas it was not detect-
able in other cell lines or in normal tissues. Interestingly, it occurred in primary neuroblastic
tumors, mainly in stroma poor neuroblastomas.
 2010 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
Dicer is an enzyme playing key roles in RNA interference (RNAi)
and microRNA (miRNA) pathways [1]. It is required for biogenesis
of small interfering RNA (siRNA) andmiRNAs during the processing
of double-stranded RNA (long dsRNA and pre-miRNAs) into short
dsRNA fragments of deﬁned length, typically 21–27 nucleotides.
Dicer is also involved in the assembly of the RNA-induced silencing
complex (RISC) that mediates the effector steps of RNA silencing
[2,3].
Dicer homologues constitute a specialized family of large mul-
tidomain RNase III-type endonucleases found in most eukaryotes,
even in unicellular eukaryotes such as Schizosaccharomyces pom-
be, Giardia intestinalis and Trypanosoma brucei. Plants, insects
and fungi contain different Dicers, with distinct roles, whereas
mammalian genomes encode only one Dicer protein [2]. ‘‘Primi-
tive” Dicers of lower eukaryotes frequently have few domains,
whereas metazoan and plant Dicer proteins generally contain an
ATPase/helicase domain, a domain of unknown function
(DUF283), a PAZ domain, two RNase III domains (RIIIa and RIIIb),
and a dsRNA-binding domain (dsRBD). The PAZ, dsRBD and RNAse
III domains are involved in dsRNA binding and cleavage. In partic-
ular, PAZ domain binds the 30-overhang-containing end of thechemical Societies. Published by E
.RNA substrate, whereas RNase IIIa and IIIb domains function as
an intramolecular pseudo-dimer forming a single processing cen-
ter containing two independent catalytic ‘‘half sites”, each capable
of cutting one RNA strand of the duplex. Mutagenesis studies on
human Dicer indicated that residues Asp1320 and Glu1652 from
RNase IIIa and Asp1709 and Glu1813 from RNase IIIb are essential
for cleavage activity of Dicer [4]. This model for Dicer–RNA inter-
action is also supported by the crystal structure Dicer from the
protozoan G. intestinalis, that lacks the N-terminal ATPase/helicase
domain and the C-terminal dsRBD [5]. The RNase III domains are
joined to form the catalytic center and show a positively charged
surface for substrate binding. The PAZ domain is connected to
RNAse III domains by a long a-helix named the ‘‘connector” helix,
which is implicated in determining the length of the dsRNA prod-
uct. This structural study also sheds some light on the role of
DUF283 domain, as the DUF283-like domain of Giardia Dicer
forms a platform-like structure providing support for the connec-
tor helix.
The Dicer region encompassing the two RNase III domains and
the dsRBD is also involved in the binding with the PPD proteins,
i.e., Argonaute and Piwi proteins, that are core components of RISC
and mediate the effector steps of RNA silencing [6].
The ATP/helicase domain has a role in the control of enzyme
activity and interacts with the two dsRBD-containing cofactors of
Dicer, i.e., TRBP and PACT, involved in siRNA-induced RNAi and
in miRNA accumulation [7–10].lsevier B.V. All rights reserved.
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cer is essential for vertebrate development [11,12]. Various tissue-
speciﬁc Dicer knockouts have also been generated showing severe
cellular or developmental defects probably due to the depletion of
miRNAs and the absence of their regulatory function [2].
Here, we report the identiﬁcation of a ﬁrst splice variant of the
human dicer gene encoding a different isoform. It lacks the dsRNA-
binding domain, its expression is restricted to neuroblastoma cells,
and correlates with the differentiation state.2. Materials and methods
2.1. Cell cultures
SK-N-BE(2)-C and HepG2 cells were grown at 37 C in RPMI
1640 containing 10% fetal bovine serum (FBS), 2 mM L-glutamine,
50 U/ml penicillin and 100 lg/ml streptomycin (Pen/Strep), in a
humidiﬁed atmosphere containing 5% CO2; SH-SY5Y cells were cul-
tured in DMEM containing 15% FBS and Pen/Strep; A-549, HEK293,
HeLa, HuH-7, MCF-7, MDA-MB-453 and PC-3 were cultured in
DMEM containing 10% FBS and Pen/strep. SK-N-BE(2)-C cells were
induced to Schwannian or neuronal cell differentiation by treat-
ment with 10 lM 5-bromo-20-deoxyuridine (BrdU) (Sigma) for
13 days or by treatment with 10 lM all-trans-retinoic acid (Sigma)
for 6 days, respectively. The onset of differentiation was monitored
by morphological analysis with a phase-contrast light microscope
and by dosing the expression levels of differentiation-related genes
by RT-PCR, as previously reported [13].
2.2. Human tissue samples
Samples of cDNA prepared from normal tissues (brain, heart,
kidney, liver, lung, pancreas, placenta, skeletal muscle and dorsal
ganglia) were obtained from Clontech.
Tumor specimens were collected at the onset of disease from 55
patients who were diagnosed with a primary neuroblastic tumor
and referred to the Gaslini Children Hospital, Genoa, Italy. The
study was approved by Ethics committee of the Gaslini Children
Hospital, and informed consent was obtained by all children’s legal
guardians. According to the International Neuroblastoma Pathol-
ogy Committee [14], 32 samples were classiﬁed as NB-SP with at
least 80% of neuroblastic cells, and 23 tumors as GNB-SR with Sch-
wannian stromal cells ranging from 80% to 90%.
Laser capture microdissection was performed on one GNB-SP
according to Albino et al. [15].
2.3. RNA extraction and RT-PCR analyses
Total RNAwas extracted from cultured cells and from tumor tis-
sues by RNeasyMini Kit (Qiagen) and by PerfectPure™RNACell Kit
(5Prime, Hamburg, Germany), including RNase-free Dnase I treat-
ment, respectively. Reverse transcription was carried out with the
SuperScript™ First-Strand Synthesis System (Invitrogen) using oli-
go-dT primers. Total RNA from microdissected cells was extracted
by PicoPure™ RNA isolation kit (Arcturus Engineering, Mountain
View, CA) and it was ampliﬁed and reverse transcribed byWT-Ova-
tion™RNAAmpliﬁcation System kit (NuGEN Technologies, San Car-
los, CA) according to manufacture’s instructions. Ampliﬁcation of
dicer cDNA sequence encompassing the last four exons was per-
formed by PCR under the following conditions: initial denaturation
step at 94 C for 2 min; 35 cycles at 94 C for 30 s, 55 C for 30 s,
72 C for 40 s; ﬁnal extension step at 72 C for 7 min. The primers
used for ampliﬁcation were F2, 50-CATGTCATTGATGACTTTGTG-
CAG-30, and R1, 50-CTGAGGTTGATTAGCTTTGAGGCT-30. Ampliﬁca-
tion products were electrophoresed on a 2% agarose gel.2.4. PCR analysis on genomic DNA
Genomic DNA was extracted from SK-N-BE(2)-C cells by using
High pure PCR template kit (Roche). PCR was performed with
primers GF (50-ACTATTACAATATAGTAGGCATACCATAAATGGT-30)
and GR (50-CTGGTTCCATTTCAAGCAATTCTC-30) under the same
conditions reported in the paragraph 2.3.
2.5. Cloning of dicer cDNAs
Dicer cDNAs from SK-N-BE(2)-C cells were ampliﬁed by PCR
performed with the Expand Long Range Kit (Roche) under the fol-
lowing conditions: initial denaturation step at 92 C for 2 min; 10
cycles at: 92 C for 10 s, 55 C for 15 s, 68 C for 6 min; 20 cycles
at 92 C for 10 s, 55 C for 15 s, 68 C for 6 min (with 20 s elonga-
tion for each successive cycle); ﬁnal extension at 68 C for 7 min.
The primers used for PCR were Fstart, 50-ACTGGATGAATG
AAAAGCCCTG-30, and Rstop, 50-GCGGTTTCAGCTATTGGGAAC-30.
The ampliﬁcation products were cloned by the TOPO XL PCR clon-
ing kit (Invitrogen) and the recombinant clones were fully se-
quenced. The sequence of t-dicer cDNA has been deposited into
the GenBank database under the accession number HM595745.3. Results and discussion
3.1. Neuroblastoma cells express a novel splice variant of dicer gene
Human dicer gene spans a region of about 71 kbp and com-
prises 29 exons (GeneID: 23405) (Fig. 1A). A number of dicer mRNA
variants have been described until now; they derive from the dif-
ferential usage of distinct promoters, varied transcriptional start
sites, alternatively spliced 50-UTR exons, and the usage of alterna-
tive intron donor sites. Importantly, all the reported transcripts en-
code the same protein because the diversity affects only the length
and composition of their 50-UTR [16,17].
RT-PCR analyses performed on RNA extracted from SK-N-BE(2)-
C neuroblastoma cells, using a forward primer (F2) lying in exon 26
and a reverse primer (R1) lying in exon 29, led to the identiﬁcation
of two ampliﬁcation products (Fig. 1B). DNA sequencing revealed
that the upper and main electrophoretic band has a molecular size
of 456 bp and corresponds to the expected PCR product of dicer
cDNA, whereas the lower electrophoretic band of 293 bp corre-
sponds to a dicer cDNA lacking the exon 27, which is part of the
coding sequence (Fig. 1).
Then, we investigated whether this cDNA could derive from
transcription of an aberrant pseudogene lacking exon 27. For this
purpose, the PCR analyses were repeated using genomic DNA as
template and the primers GF and GR that hybridize upstream of
the exon 27 and to the exon 28, respectively, that are expected
to yield products of convenient sizes. Ampliﬁcation of the true di-
cer gene should yield a product of 467 bp, whereas the ampliﬁca-
tion of an eventual genomic DNA segment lacking exon 27 will
give a product of 304 bp. As shown in Fig. 2A only one product
was detected, and it derived from the authentic dicer gene. This re-
sult strongly suggested that the newly identiﬁed cDNA lacking
exon 27 derives from an alternatively spliced dicer mRNA.
Based on these data, we tried to isolate the entire coding
sequence of the variant. A RT-PCR was carried out by using another
couple of primers, Fstart and Rstop, that hybridize to the ends of
the coding sequence (Fig. 1); the PCR products should contain
the canonic transcript (5784 bp) and the alternatively spliced one
(5621 bp) (Fig. 2B). Afterward the PCR products were cloned in
pCR-XL-TOPO vector and a preliminary restriction analysis al-
lowed us to identify clones containing the known dicer coding se-
quence and ones lacking exon 27. Finally, these clones were fully
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Fig. 1. Structure of dicer gene and evidence for a new splice variant. (A) Gene structure of dicer. The exons are represented by black boxes; the introns larger than 1kbp are
not in scale; the positions of start and stop codons and the hybridization sites for Fstart and Rstop primers are also indicated; the blow up shows the 30 region of dicer gene
with the indication of the alternative splicing schemes (a and b), and the exon numbers. (B) Electrophoretic analysis of PCR products obtained by ampliﬁcation of cDNA from
SK-N-BE(2)-C neuroblastoma cells (lane 2) using primers F2 and R1; lane 1, negative control of PCR performed without template.
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Fig. 2. PCR analyses on genomic DNA and cDNA from SK-N-BE(2)-C neuroblastoma
cells. (A) Agarose gel electrophoresis of PCR product obtained by ampliﬁcation of
genomic DNA with primers GF and GR. (B) PCR products obtained by ampliﬁcation
of cDNA with primers Fstart and Rstop. (C), negative control from a PCR performed
without template; (M0), 100 bp ladder molecular weight marker (GE Healthcare);
(M00), DNA molecular weight Marker III (Roche).
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script of dicer gene with an altered coding sequence. In particular,
the skipping of exon 27 removes part of the coding sequence and
changes the reading frame, leading to a premature stop codon.
As a consequence, the encoded truncated protein, called t-Dicer,
is 93 amino acids shorter than Dicer, with the last 41 amino acids
being different in the two proteins (Fig. 3A). Comparison of the
amino acid sequences of the two proteins then revealed that t-Di-
cer lacks the C-terminal dsRBD and possesses an altered RNase
RIIIb domain lacking the catalytic residue E1813 (Fig. 3B). In con-
clusion, our results show that the SK-N-BE(2)-C neuroblastoma
cells can alternatively splice dicer pre-mRNA leading to a mature
transcript lacking exon 27 and encoding a truncated Dicer protein.
Previous mutational studies have shown that truncated human
Dicer proteins lacking the dsRBD have an unaltered substrate afﬁn-
ity and a moderately decreased rate of RNA cleavage [4,7]. Further-
more, a few naturally occurring Dicers lacking the dsRNA-bindingdomain have been characterized, suggesting that this region is dis-
pensable for substrate binding and catalysis [18]. In the absence of
the dsRBD, the RNA-binding ability should be provided by the two
RNase III and the PAZ domains. On the basis of these data, we
hypothesize that t-Dicer should be able to bind the substrate and
to cleave only one RNA strands, because of the absence of E1813
in one of the two catalytic subunits.
3.2. Expression of t-dicer in other cell lines and tissues
We performed RT-PCR by using F2 and R1 primers to check the
presence of the new splice variant in SH-SY5Y neuroblastoma cell
line, embryonic kidney cells (HEK293), hepatocellular carcinoma
cells (HepG2 and HuH-7), lung carcinoma cells (A-549), breast car-
cinoma cells (MCF-7 and MDA-MB-453), prostate carcinoma cells
(PC-3), and cervix carcinoma cells (HeLa). Analysis of the ampliﬁ-
cated products by gel electrophoresis showed that SH-SY5Y neuro-
blastoma cell line expressed the splice variant, whereas all the
other cell lines expressed only the wild-type dicer (Fig. 4A).
Next, we investigated whether t-dicer was present in normal
human tissues. To this purpose cDNAs from brain, heart, kidney, li-
ver, lung, pancreas, placenta, and skeletal muscle were analyzed
revealing that wild-type dicer is ubiquitously expressed, as ex-
pected, whereas t-dicer is never detectable (Fig. 4B). Human dorsal
ganglia, from which neuroblastomas often arise, were also ana-
lyzed, revealing the absence of t-dicer (data not shown). These data
indicate that t-dicer is exclusively present in neuroblastoma cell
lines.
Neuroblastoma SK-N-BE(2)-C is considered an intermediate
type (I-type) cell line because it shows features of both neural
(N-type) and sub-adherent Schwannian-like (S-type) cells. There-
fore, SK-N-BE(2)-C cells may represent stem cells or differentiation
intermediates from which both N-type and S-type cells arise. In
fact, they are capable both of self-renewal and of bidirectional
differentiation to either N-type or S-type cells when induced by
speciﬁc agents [13]. Thus, SK-N-BE(2)-C cells were induced to ter-
minally differentiate to N-type phenotype or to S-type phenotype
and we tested the t-dicer expression by RT-PCR. This analysis
showed that t-dicer is well detectable in N-type cells, whereas it
is not found in S-type cells (Fig. 4C). This result suggests that the
alternative splicing generating t-dicer may be regulated since the
splice variant is expressed in the initial state and in only one of
the two terminal differentiation states.
Fig. 3. Comparison of Dicer and t-Dicer proteins. (A) Schematic representation of Dicer domains. The C-terminal 41 amino acids of t-Dicer, deriving from the altered reading
frame, are indicated by the black box. (B) Alignment of the amino acid sequences encoded by the last four or three exons of dicer and t-dicer transcripts, respectively. The
alignment was performed by Clustal W. The catalytic amino acids of the RNase IIIb domain are marked by arrowheads.
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Fig. 4. Expression proﬁles of t-dicer. (A) Agarose gel electrophoresis of PCR
products obtained by ampliﬁcation cDNAs from SK-N-BE(2)-C (SK), SH-SY5Y (SH),
HEK293 (HK), HepG2 (HP), HuH-7 (Hu), A-549 (A), MCF-7 (MC), MDA-MB-453
(MD), PC-3 (PC) and HeLa (H) cells. (B) PCR products obtained by ampliﬁcation of
cDNAs from brain (B), heart (H), kidney (K), liver (Li), lung (Lu), pancreas (Pa),
placenta (Pl), skeletal muscle (Sm), and SK-N-BE(2)-C cells (SK) used as positive
control. (C) RT-PCR products obtained from undifferentiated SK-N-BE(2)-C cells (I, I-
type), cells induced to Schwannian differentiation (S, S-type) and cells induced to
neuronal differentiation (N, N-type). (C-), negative control from a PCR performed
without template; (M0), 50 bp ladder molecular weight marker (GE Healthcare);
(M00), DNA molecular weight Marker XIV (Roche). All the PCR reactions were
performed with F2 and R1 primers.
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neuroblastoma cells and in neuroblastoma cells induced to neuro-nal differentiation, whereas it is not detectable in normal tissues,
including dorsal ganglia. We hence investigated the presence of
t-dicer in primary human neuroblastic tumors.
3.3. Expression of t-dicer in primary neuroblastoma tumors
Neuroblastoma is the most common solid extracranial tumor in
childhood, originating from the sympathetic precursor cells de-
rived from the neural crest [19]. It belongs to neuroblastic tumors,
a group of pediatric cancers with a great clinical and biological het-
erogeneity. These tumors range from localized (stages 1, 2 and 3)
to disseminated disease (stages 4 and 4S). Stage 4S occurs in infant
and is characterized by localized primary tumors andmetastases in
several organs but not involving the skeleton. Neuroblastoma Sch-
wannian stroma poor (NB-SP) represents aggressive tumors occur-
ring in patients older than 1 year of age at diagnosis. They are
composed of small round undifferentiated neuroblastic cells with-
out Schwannian stromal cells. Tumors with a favorable prognosis
are ganglioneuroblastoma intermixed Schwannian stroma rich
(GNB-SR), mostly composed of large Schwannian stromal cells in
which some nests of neuroblastic cells are embedded [14]. The
expression of t-dicer in tumors was evaluated by the RT-PCR anal-
ysis performed on 55 primary neuroblastic tumors of different clin-
ical stages and with different histology, i.e., neuroblastoma
Schwannian stroma poor (>80% of neuroblasts) or ganglioneuro-
blastoma intermixed Schwannian stroma rich (Fig. 5). The results
showed that t-dicer was detectable in 29 tumors, corresponding
to 53% of the samples, with a not obvious correlation with the stage
of the tumor (Table 1). Interestingly, t-dicer was found to be ex-
pressed in 21 out of 32 (66%) NB-SP tumors, signiﬁcantly
(P < 0.05, Fisher test) more than in GNB-SR, where only 8 out of
23 (35%) samples expressed t-dicer (Table 1).
Our study on neuroblastic tumor was then extended by exam-
ining neuroblasts and Schwannian stromal cells isolated by laser
AB
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Fig. 5. Expression of t-dicer in tumors. Representative agarose gel electrophoretic
analyses of the RT-PCR products obtained by ampliﬁcation of RNA extracted from
eight samples of GNB-SP (A) and NB-SR (B). M, 100 bp ladder molecular weight
marker.
Table 1
Expression of t-dicer in neuroblastic tumors.
Tumor
histology
Tumor
stage
Number of
tumors
t-Dicer positive
tumors
NB-SP 1 9 8
NB-SP 2A 2 1
NB-SP 2B 4 2
NB-SP 3 1 0
NB-SP 4 10 5
NB-SP 4S 6 5
GNB-SR 1 16 5
GNB-SR 2A 2 0
GNB-SR 3 3 2
GNB-SR 4 2 1
NB-SP: neuroblastoma Schwannian stroma poor; GNB-SR: ganglioneuroblastoma
intermixed Schwannian stroma rich.
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Shwannian stroma rich sample. t-Dicer was detectable only in neu-
roblastic cells (data not shown) consistent with the data in vitro
collected in SK-N-BE(2)-C cells, where the expression of t-dicer
was evident in the N-type cells and undetectable in the S-type
cells. These ﬁndings may suggest a correlation of t-dicer expression
with the differentiation state of cells.
There is increasing evidence about the importance of the Dicer-
mediated miRNA pathway in the neuronal differentiation and in
the pathogenesis of neural tumors. For example, different timings
of Dicer deletion affect neurogenesis and gliogenesis in the devel-
oping mouse central nervous system [20]. Moreover, Dicer is re-
quired for survival of differentiating neural crest cells [21].
Furthermore, differential patterns of miRNAs in neuroblastoma
are correlated with prognosis, differentiation and apoptosis
[22,23]. In this scenario, our results provide a strong basis for fur-
ther studies to elucidate the possible relationship between t-dicer
expression and cell differentiation.
3.4. Conclusions
A new splice variant of human dicer gene has been identiﬁed,
the ﬁrst one bearing a modiﬁed coding sequence. It encodes a
variant of Dicer protein, t-Dicer, that lacks the dsRNA-binding
domain and is defective in one of the two RNase III catalytic
centers. Nevertheless, t-dicer should be able to bind the RNA
substrate and cleave one of the two RNA strand, possibly yield-
ing a partially processed pre-miRNA. T-dicer is expressed in neu-
roblastoma cells and tumors but it is undetectable in dorsal
ganglia and in other normal tissues. Moreover, its expression
correlates with the neuroblast differentiation state. In this re-gard, it will be interesting to inquire whether t-dicer is simply
a sign of neuroblastoma development or it plays a role in the
differentiation and tumorogenesis. Given the importance of Dicer
and miRNAs in neural differentiation, it cannot be ruled out the
possibility that t-Dicer, cleaving only one strand of pre-miRNAs,
may leave them in a partially processed state, leading to an
aberrant maturation that may interfere with wild-type Dicer
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